GL1X · GenesisL1 explorer

MolNFT v1 · #122913 · protein

Crystal structure of the catalytic domain of human tyrosyl DNA phosphodiesterase 2 in complex with a small molecule inhibitor

5J3S · Tyrosyl-DNA phosphodiesterase 2: “Crystal structure of the catalytic domain of human tyrosyl DNA phosphodiesterase 2 in complex with a small…”. X-ray diffraction, 1 ligand (6FQ), 2 pockets (best druggability 0.49). MolNFT v1 #122913…

PDB
5J3S
Type
protein
Length
236 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosyl-DNA phosphodiesterase 2
EC
3.1.4.-
UniProt
O95551
Ligands
6FQ
Pockets
2 · best druggability 0.49

Structure

x-ray diffraction · 1 distinct chain · 20% helix, 34% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosyl-DNA phosphodiesterase 2 (EC 3.1.4.-)protein23620% helix, 34% strandO95551

Ligands and binding sites

  • 6FQ · 2,4-dioxo-10-[3-(1H-tetrazol-5-yl)phenyl]-2,3,4,10-tetrahydropyrimido[4,5-b]quinoline-8-carbonitrile · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1620.490.8515empty
2540.420.8216empty

Compared structures

  • 5J3S · Crystal structure of the catalytic domain of human tyrosyl DNA phosphodiesterase 2 in… · the same entry in another collection · chain A against A, TM-score 1.00
  • O95551 · AlphaFold monomer V2.0 prediction for tyrosyl-DNA phosphodiesterase 2 (O95551) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.